RxDoctor Payments Data

Jacqueline Moore

Women's Health · Charleston, SCNPI 1447223706

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 120 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AbbVie at 25.4% of the total. Reporting peaked in 2022 at $1,252 and has fallen 92.7% since, to $92 in 2024. Among women's health clinicians in SC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,920in general payments, 2019–2025

Across 120 payments — averaging $16.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$488
  • Therapeuticsmd, Inc.$188
  • Exeltis, USA Inc.$169
  • Mayne Pharma Commercial LLC$144
  • Mylan Pharmaceuticals Inc.$118
  • Aspira Women's Health Inc$99
  • plus $714 from 16 others

What the payments were for

  • Food & beverage$1,920100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,920 in reported general payments places this provider in the 90th percentile of 62 women's health providers in South Carolina.

See all women's health providers in South Carolina

Medicare billing

Part B allowed, 2024
$4,129
Medicare patients
54
Services billed
101

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol24$1,704
ValacyclovirValacyclovir Hcl16$839
Estradiol (Once Weekly)Estradiol13$600
Terconazole11$233

Paid to pharmacies, not to this prescriber.

Other women's health in Charleston

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →